As of June 2023, it was forecasted that in 2027 global sales for the leading three pharmaceutical cannabis products will stand at nearly 1.4 billion U.S. dollars. The three major products are Epidiolex, Dronabinol, and Sativex. This statistic illustrates the estimated sales forecast of major cannabis pharmaceutical products worldwide from 2023 to 2027.